IntelliPharmaCeutics International Inc (IPCI)

1.36
1.13 45.38
NASDAQ : Health Care
Prev Close 2.49
Open 1.64
Day Low/High 1.30 / 1.80
52 Wk Low/High 1.41 / 3.67
Volume 3.51M
Avg Volume 246.90K
Exchange NASDAQ
Shares Outstanding 30.57M
Market Cap 76.13M
EPS -0.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of IntelliPharmaCeutics International Inc.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors Of An Investigation Involving Possible Securities Fraud Violations By The Board Of Directors Of IntelliPharmaCeutics International Inc.

Levi & Korsinsky announces it has commenced an investigation of IntelliPharmaCeutics International Inc.

IIROC Trade Resumption - IPCI

IIROC Trade Resumption - IPCI

IIROC Trading Halt - IPCI

IIROC Trading Halt - IPCI

Canadian Pharma Goes Before FDA Panel Wednesday on Tamper Resistant Opioid

Canadian Pharma Goes Before FDA Panel Wednesday on Tamper Resistant Opioid

IntelliPharmaceuticals has a bio-equivalent to OxyContin, but says it is harder to tamper with. The pharma company is hoping to gain a recommendation from an FDA committee on Wednesday.

Interesting IPCI Put And Call Options For July 2017

Interesting IPCI Put And Call Options For July 2017

Investors in IntelliPharmaCeutics International Inc saw new options begin trading this week, for the July 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 235 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Interesting IPCI Put And Call Options For December 16th

Interesting IPCI Put And Call Options For December 16th

Investors in IntelliPharmaCeutics International Inc saw new options begin trading this week, for the December 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the IPCI options chain for the new December 16th contracts and identified one put and one call contract of particular interest.

Intellipharmaceutics (IPCI) Stock Climbs on Licensing Agreeement

Intellipharmaceutics (IPCI) Stock Climbs on Licensing Agreeement

Intellipharmaceutics (IPCI) and Mallinckrodt (MNK) have reached a license and commercial supply agreement.